Charles River Laboratories Inter (NYSE: CRL) has reported a loss for its fourth fiscal quarter (ending December 31) of $-4.22 versus $3.65 for the same period a year ago — a decline of -216%. For the latest four quarters through December 31, E.P.S. were $0.20 compared to $9.27 a year ago — a decline of -98%.
Recent Price Action
Charles River Laboratories Inter (NYSE: CRL) stock enjoyed a very large increase of 6.9% on 2/19/25. The shares closed at $165.00. Moreover, trading volume in this advance was exceptionally high at 221% of normal. The stock has been weak relative to the market over the last nine months but has risen 3.2% during the last week.
Current PriceTarget Research Rating
Charles River Laboratories Inter has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Charles River Laboratories Inter has a good Appreciation Score of 74 but a very low Power Rating of 9, producing the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment